New Approaches to Microbiome-Based Therapies

ABSTRACT Over the last decade, our understanding of the composition and functions of the gut microbiota has greatly increased. To a large extent, this has been due to the development of high-throughput genomic analyses of microbial communities, which have identified the critical contributions of the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andrea C. Wong, Maayan Levy
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://doaj.org/article/b096209cbfcb48809b097e57ef319385
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b096209cbfcb48809b097e57ef319385
record_format dspace
spelling oai:doaj.org-article:b096209cbfcb48809b097e57ef3193852021-12-02T18:44:39ZNew Approaches to Microbiome-Based Therapies10.1128/mSystems.00122-192379-5077https://doaj.org/article/b096209cbfcb48809b097e57ef3193852019-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSystems.00122-19https://doaj.org/toc/2379-5077ABSTRACT Over the last decade, our understanding of the composition and functions of the gut microbiota has greatly increased. To a large extent, this has been due to the development of high-throughput genomic analyses of microbial communities, which have identified the critical contributions of the microbiome to human health. Consequently, the intestinal microbiota has emerged as an attractive therapeutic target. The large majority of microbiota-targeted therapies aim at engineering the intestinal ecosystem by means of probiotics or prebiotics. Recently, a novel therapeutic approach has emerged which focuses on molecules that are secreted, modulated, or degraded by the microbiome and act directly on the host. Here, we discuss the advantages and challenges associated with the metabolite-based “postbiotic” approach, highlighting recent progress and the areas that need intensive attention and investigation over the next 5 years. The time is ripe for postbiotic therapies to be developed in the near future.Andrea C. WongMaayan LevyAmerican Society for Microbiologyarticlegnotobioticsmetabolitesmetagenomicsmicrobiomemicrobiome-based therapiespostbioticsMicrobiologyQR1-502ENmSystems, Vol 4, Iss 3 (2019)
institution DOAJ
collection DOAJ
language EN
topic gnotobiotics
metabolites
metagenomics
microbiome
microbiome-based therapies
postbiotics
Microbiology
QR1-502
spellingShingle gnotobiotics
metabolites
metagenomics
microbiome
microbiome-based therapies
postbiotics
Microbiology
QR1-502
Andrea C. Wong
Maayan Levy
New Approaches to Microbiome-Based Therapies
description ABSTRACT Over the last decade, our understanding of the composition and functions of the gut microbiota has greatly increased. To a large extent, this has been due to the development of high-throughput genomic analyses of microbial communities, which have identified the critical contributions of the microbiome to human health. Consequently, the intestinal microbiota has emerged as an attractive therapeutic target. The large majority of microbiota-targeted therapies aim at engineering the intestinal ecosystem by means of probiotics or prebiotics. Recently, a novel therapeutic approach has emerged which focuses on molecules that are secreted, modulated, or degraded by the microbiome and act directly on the host. Here, we discuss the advantages and challenges associated with the metabolite-based “postbiotic” approach, highlighting recent progress and the areas that need intensive attention and investigation over the next 5 years. The time is ripe for postbiotic therapies to be developed in the near future.
format article
author Andrea C. Wong
Maayan Levy
author_facet Andrea C. Wong
Maayan Levy
author_sort Andrea C. Wong
title New Approaches to Microbiome-Based Therapies
title_short New Approaches to Microbiome-Based Therapies
title_full New Approaches to Microbiome-Based Therapies
title_fullStr New Approaches to Microbiome-Based Therapies
title_full_unstemmed New Approaches to Microbiome-Based Therapies
title_sort new approaches to microbiome-based therapies
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/b096209cbfcb48809b097e57ef319385
work_keys_str_mv AT andreacwong newapproachestomicrobiomebasedtherapies
AT maayanlevy newapproachestomicrobiomebasedtherapies
_version_ 1718377699360112640